US FDA greenlights nivolumab for use before surgery for NSCLC

Tumor Growth Rate as a Guide for Precision Lung Cancer Therapy

Patient Perspective: The Promise of Personalized Medicine

Cancer Misinformation: Its Impact on Patients and Mitigation Strategies

A Look at Veliparib Plus Chemotherapy for First-Line Treatment of Advanced NSCLC

TIL Therapy Endures for Carefully Selected Patients: A Q&A with Dr. Benjamin C. Creelan

Early Palliative Care: A European Perspective

Financial Toxicity of Lung Cancer in the Netherlands

As Treatment Options in Lung Cancer Have Expanded, so Have Costs

Small, High PLCG2-Expressing Intratumoral Cells May Drive Metastasis

COAST Data Support Further Research of Immunotherapy Combinations

Alternative Dosing Strategies for Immune Checkpoint Inhibitors